EBOLA VIRUS DISEASE
Clinical trials for EBOLA VIRUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new EBOLA VIRUS DISEASE trials appear
Sign up with your email to follow new studies for EBOLA VIRUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ebola survivors get vaccine booster to ward off return of the virus
⭐️ VACCINE ⭐️ OngoingThis study looks at whether a booster dose of the Ebola vaccine (ERVEBO) can strengthen the immune system of people who have already survived Ebola. Researchers will compare their response to that of healthy people who have never had the virus. The goal is to see if the booster p…
Matched conditions: EBOLA VIRUS DISEASE
Phase: PHASE4 • Sponsor: Tulane University • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:04 UTC
-
Ebola vaccine memory under the microscope: how long does it last?
Knowledge-focused OngoingThis study gives 30 healthy adults a single dose of the approved Ebola vaccine (Ervebo) and tracks their immune responses over time using blood, lymph node, and bone marrow samples. The goal is to understand how long the body 'remembers' the vaccine, which could guide future boos…
Matched conditions: EBOLA VIRUS DISEASE
Phase: PHASE2 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC